Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of “Global Coagulation Testing Market” – which is forecasted from 2020 to 2027”.
The key growth factors attributing to the growth of the Global Coagulation Testing Market in the forecasted period are the rising geriatric population and increasing cardiovascular, liver, and blood-related disorders. Advancements in research and development in the field and the production of new coagulation devices are expected to augment the market growth further.
As per the report, Global Coagulation Testing Market is expected to grow at a CAGR of 4.16% to reach US$3,612.665 million by 2027, from US$2,715.944 million in 2020.
Coagulation tests are performed to diagnose and analyze the patient’s hemostasis system to understand the risk of developing thrombosis or excessive bleeding in the patient’s body. This test is usually carried out with a coagulometer, which monitors and evaluates the rate at which blood clots or coagulates. Heart attack, thrombosis, or embolism can all be caused by a blood clot in a blood vessel. The test helps in the detection of such anomalies in the preliminary stages, thereby reducing the development of these conditions into severe cases. The increased prevalence of blood-related disorders and lung cancer are increasing the demands for such tests. The rising aged population is further augmenting the need for this test. According to WHO, the number of health anomalies increases with an increase in age. Furthermore, according to Leukemia and Lymphoma Society, one person in the US is diagnosed with leukemia, lymphoma, or myeloma every three minutes in 2021. At the same time, the rapid advancements in research of the diseases and the devices to meet the surging demand are also fueling the market growth. The key developments deployed by the leading companies and governments of various countries globally unleash new possibilities for the market.
On the basis of the types of tests, the coagulation testing market is bifurcated into Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Platelet Function Tests and others.
On the basis of end users, the market is further segmented into Hospitals and Clinics, Diagnostic Centers, and Ambulatory Care Centers. The growing number of infected cases is expected to increase the demand for the devices in the diagnostic centers and hospitals.
On the basis of geography, the market is segmented into North America, South America, Asia Pacific, Europe, and Middle East and Africa.
The enforcement of statewide lockdowns and social distancing laws amidst the pandemic in several countries has significantly influenced the worldwide economy. The increase in the infected population, closure of manufacturing facilities, and the paucity of raw materials and personnel have also impacted the market. Although, during the pandemic, greater consumer awareness of health and cleanliness and increased consumption of nutritional components will undoubtedly contribute to the market's growth.
As a part of the report, the key players active in the Coagulation Testing Market, that have been covered are Diagnostica Stago, S.A.S., F. Hoffmann-La Roche Ltd, Enzyme Research Laboratories Ltd, Stago Group, Abbott, Sekisui Medical Co., Ltd., Universal Biosensors, Coagulation Sciences LLC, RUSNANO Group, and Stago Group
View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/global-coagulation-testing-market
This analytics report segments the Coagulation Testing Market on the following basis:
- By Test Type
- Prothrombin Time Testing
- Fibrinogen Testing
- Activated Clotting Time Testing
- Platelet Function Tests
- By End Users
- Hospitals and Clinics
- Diagnostic Centres
- Ambulatory Care Centres
- By Geography
- North America
- United States
- South America
- United Kingdom
- Middle East and Africa
- Saudi Arabia
- Asia Pacific
- South Korea
- North America